Skip to main content
logo
AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.1974
+0.0053 (2.76%)
Aug 24, 2026, 4:00 PM EDT - Market closed

AEON Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-54.62-39.2242.01-384.63-52.56-55.64
Depreciation & Amortization
0.080.080.10.10.070
Other Amortization
----0.331.98
Asset Writedown & Restructuring Costs
---348--
Stock-Based Compensation
5.65.326.2575.895.22
Other Operating Activities
35.1423.46-69.35-15.554.4118.59
Change in Accounts Payable
-1.21-4.972.52-4.596.61-0.9
Change in Other Net Operating Assets
1.38-1.97-1.821.85-0.352.31
Operating Cash Flow
-13.64-17.31-20.29-47.83-35.58-28.43
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
--0---0.31-0.17
Investing Cash Flow
--0---0.31-0.17

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--151444.515
Long-Term Debt Repaid
-----3.99-
Total Debt Repaid
-----3.99-
Net Debt Issued (Repaid)
--151440.5115
Issuance of Common Stock
2.6418.510.15---
Other Financing Activities
61.79----1.44
Financing Cash Flow
8.6320.3115.151440.5113.56

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-5.012.99-5.15-33.834.62-15.04

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-13.64-17.31-20.29-47.83-35.89-28.6
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.47-1.75-35.23-0.62-18.61-16.31
Levered Free Cash Flow
-7.19-11-10.3-25.48-16.79-14.85
Unlevered Free Cash Flow
-7.19-11-10.3-25.48-16.79-14.85

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
0.17-6.940.71-2.746.271.42
SEC Filings: 10-K · 10-Q